Human coronavirus 229E 3C-like protease (3CLpro)

The Human coronavirus 229E (hCoV-229E) 3C-like protease, also known as the main protease (Mpro) or nonstructural protein 5 (nsp5), is a key enzyme required for the processing of viral polyproteins and subsequent viral replication [1, 2]. As a cysteine protease, it functions as a homodimer and specifically cleaves the replicase polyproteins pp1a and pp1ab at eleven distinct sites, releasing essential nonstructural proteins [2, 6]. In addition to its role in the viral life cycle, hCoV-229E 3CLpro acts as an antagonist of the host innate immune system by cleaving signaling proteins such as NEMO and MDA5, thereby dampening the interferon response [8, 10]. Due to its essentiality for the virus and the absence of closely related human homologs, it is a high-priority target for the development of broad-spectrum antiviral therapies [5, 14]. Small molecule inhibitors, including peptidomimetics like nirmatrelvir and GC376, target the enzyme's active site to block its proteolytic activity and inhibit viral spread [5, 11, 16].

Other names

Main proteaseMpronsp5C30 endopeptidase3C-like proteinaseHuman coronavirus 229E main protease

The mechanism of action involves the inhibition of the 3C-like protease's catalytic activity by binding to the active site, typically forming a covalent bond with the catalytic cysteine residue (Cys144). This prevents the enzyme from cleaving the viral polyproteins pp1a and pp1ab into functional nonstructural proteins, thereby halting viral replication and assembly [2, 3, 5].